$CHCO
City Holding Co Stock $chco

$chco Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000072685421000093 Filed on May 06, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$40.94M	$48.22M
YoY Change	-15.1%	-1.46%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.440M	$1.325M
YoY Change	8.68%	9.59%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$3.397M	$7.801M
YoY Change	-56.45%	-12.02%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$24.80M	$36.32M
YoY Change	-31.72%	31.43%
Income Tax	$4.987M	$7.322M
% Of Pretax Income	20.11%	20.16%
Net Earnings	$19.81M	$29.00M
YoY Change	-31.67%	34.12%
Net Earnings / Revenue	48.4%	60.14%
Basic Earnings Per Share	$1.25	$1.79
Diluted Earnings Per Share	$1.25	$1.78
COMMON SHARES
Basic Shares Outstanding	15.66M shares	16.08M shares
Diluted Shares Outstanding	15.69M shares	16.10M shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.969B	$1.072B
YoY Change	83.77%	9.3%
Cash & Equivalents	$756.8M	$110.6M
Short-Term Investments	$1.212B	$960.9M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$76.53M	$78.95M
YoY Change	-3.06%	0.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.400M	$2.200M
YoY Change	-36.36%	-82.68%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$5.894B	$5.088B
YoY Change	15.84%	3.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$316.0M	$224.2M
YoY Change	40.95%	15.15%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$316.0M	$224.2M
YoY Change	40.95%	15.15%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$89.80M	$117.0M
YoY Change	-23.25%	106.71%
Total Long-Term Liabilities	$89.80M	$117.0M
YoY Change	-23.25%	92.75%
TOTAL LIABILITIES
Total Short-Term Liabilities	$316.0M	$224.2M
Total Long-Term Liabilities	$89.80M	$117.0M
Total Liabilities	$5.203B	$4.403B
YoY Change	18.16%	2.44%
SHAREHOLDERS EQUITY
Retained Earnings	$600.4M	$556.7M
YoY Change	7.85%	11.6%
Common Stock	$218.1M	$217.7M
YoY Change	0.2%	-0.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$142.5M	$116.7M
YoY Change	22.13%	27.38%
Treasury Stock Shares	3.324M shares	2.907M shares
Shareholders Equity	$691.7M	$685.2M
YoY Change
Total Liabilities & Shareholders Equity	$5.894B	$5.088B
YoY Change	15.84%	3.47%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	$19.81M	$29.00M
YoY Change	-31.67%	34.12%
Depreciation, Depletion And Amortization	$1.440M	$1.325M
YoY Change	8.68%	9.59%
Cash From Operating Activities	$19.40M	$23.13M
YoY Change	-16.11%	15.28%
INVESTING ACTIVITIES
Capital Expenditures	$1.048M	$3.329M
YoY Change	-68.52%	111.23%
Acquisitions
YoY Change
Other Investing Activities	$59.70M	-$22.20M
YoY Change	-368.92%	-253.1%
Cash From Investing Activities	$58.65M	-$25.58M
YoY Change	-329.33%	-297.75%
FINANCING ACTIVITIES
Cash Dividend Paid	$9.249M	$9.293M
YoY Change	-0.47%	5.9%
Common Stock Issuance & Retirement, Net	$5.762M	$12.97M
YoY Change	-55.58%	217.22%
Debt Paid & Issued, Net	$0.00	$4.124M
YoY Change	-100.0%
Cash From Financing Activities	$150.1M	-$27.06M
YoY Change	-654.65%	122.97%
NET CHANGE
Cash From Operating Activities	$19.40M	$23.13M
Cash From Investing Activities	$58.65M	-$25.58M
Cash From Financing Activities	$150.1M	-$27.06M
Net Change In Cash	$228.1M	-$29.51M
YoY Change	-873.15%	-241.46%
FREE CASH FLOW
Cash From Operating Activities	$19.40M	$23.13M
Capital Expenditures	$1.048M	$3.329M
Free Cash Flow	$18.35M	$19.80M
YoY Change	-7.3%	7.1%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000726854
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2019	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201613Member
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	0-11733
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	CITY HOLDING COMPANY
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WV
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	55-0619957
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	25 Gatewater Road,
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Charleston,
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	WV
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	25313
CY2021Q1	dei	City Area Code CityAreaCode	304
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	769-1100
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15681947	shares
CY2021Q1	us-gaap	Cash And Due From Banks CashAndDueFromBanks	97709000	USD
CY2020Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	77412000	USD
CY2021Q1	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	659090000	USD
CY2020Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	451247000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	756799000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	528659000	USD
CY2021Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	1185245000	USD
CY2020Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	1178789000	USD
CY2021Q1	chco	Other Investment Securities OtherInvestmentSecurities	27182000	USD
CY2020Q4	chco	Other Investment Securities OtherInvestmentSecurities	27372000	USD
CY2021Q1	us-gaap	Marketable Securities MarketableSecurities	1212427000	USD
CY2020Q4	us-gaap	Marketable Securities MarketableSecurities	1206161000	USD
CY2021Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	3546723000	USD
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	3622119000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	24076000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	24549000	USD
CY2021Q1	us-gaap	Notes Receivable Net NotesReceivableNet	3522647000	USD
CY2020Q4	us-gaap	Notes Receivable Net NotesReceivableNet	3597570000	USD
CY2021Q1	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	118976000	USD
CY2020Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	118243000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	76529000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	76925000	USD
CY2021Q1	us-gaap	Interest Receivable InterestReceivable	16231000	USD
CY2020Q4	us-gaap	Interest Receivable InterestReceivable	15793000	USD
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1395000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	USD
CY2021Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	118224000	USD
CY2020Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	118592000	USD
CY2021Q1	us-gaap	Other Assets OtherAssets	71142000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	96697000	USD
CY2021Q1	us-gaap	Assets Assets	5894370000	USD
CY2020Q4	us-gaap	Assets Assets	5758640000	USD
CY2021Q1	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	1244175000	USD
CY2020Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	1176990000	USD
CY2021Q1	us-gaap	Demand Deposit Accounts DemandDepositAccounts	1077749000	USD
CY2020Q4	us-gaap	Demand Deposit Accounts DemandDepositAccounts	1027201000	USD
CY2021Q1	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	1265038000	USD
CY2020Q4	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	1188003000	USD
CY2021Q1	us-gaap	Time Deposits TimeDeposits	1209873000	USD
CY2020Q4	us-gaap	Time Deposits TimeDeposits	1260022000	USD
CY2021Q1	us-gaap	Deposits Deposits	4796835000	USD
CY2020Q4	us-gaap	Deposits Deposits	4652216000	USD
CY2021Q1	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	316003000	USD
CY2020Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	295956000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3202000	USD
CY2021Q1	us-gaap	Other Liabilities OtherLiabilities	89847000	USD
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	106160000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	5202685000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	5057534000	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	25
CY2021Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	25
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	2.50
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	2.50
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19047548	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19047548	shares
CY2021Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	3323801	shares
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	3280040	shares
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	47619000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	47619000	USD
CY2021Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	170526000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	171304000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	600396000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	589988000	USD
CY2021Q1	us-gaap	Treasury Stock Value TreasuryStockValue	142484000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	139038000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	21289000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	36894000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	5661000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	5661000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	15628000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	31233000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	691685000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	701106000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5894370000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5758640000	USD
CY2021Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	34324000	USD
CY2020Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	41335000	USD
CY2021Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	5242000	USD
CY2020Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	5871000	USD
CY2021Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	1253000	USD
CY2020Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	707000	USD
CY2021Q1	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	118000	USD
CY2020Q1	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	304000	USD
CY2021Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	40937000	USD
CY2020Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	48217000	USD
CY2021Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	3280000	USD
CY2020Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	7238000	USD
CY2021Q1	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	117000	USD
CY2020Q1	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	464000	USD
CY2021Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	0	USD
CY2020Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	100000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	3397000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	7802000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	37540000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	40415000	USD
CY2021Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-440000	USD
CY2020Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	7972000	USD
CY2021Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	37980000	USD
CY2020Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	32443000	USD
CY2021Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	283000	USD
CY2020Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	63000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-51000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-2402000	USD
CY2021Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	1460000	USD
CY2020Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	1676000	USD
CY2021Q1	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	0	USD
CY2020Q1	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	17837000	USD
CY2021Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	811000	USD
CY2020Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	1536000	USD
CY2021Q1	us-gaap	Noninterest Income NoninterestIncome	16630000	USD
CY2020Q1	us-gaap	Noninterest Income NoninterestIncome	33347000	USD
CY2021Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	15671000	USD
CY2020Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	15851000	USD
CY2021Q1	us-gaap	Occupancy Net OccupancyNet	2622000	USD
CY2020Q1	us-gaap	Occupancy Net OccupancyNet	2488000	USD
CY2021Q1	us-gaap	Equipment Expense EquipmentExpense	2544000	USD
CY2020Q1	us-gaap	Equipment Expense EquipmentExpense	2429000	USD
CY2021Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	405000	USD
CY2020Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	0	USD
CY2021Q1	us-gaap	Advertising Expense AdvertisingExpense	881000	USD
CY2020Q1	us-gaap	Advertising Expense AdvertisingExpense	843000	USD
CY2021Q1	chco	Bankcard Expenses BankcardExpenses	1584000	USD
CY2020Q1	chco	Bankcard Expenses BankcardExpenses	1435000	USD
CY2021Q1	us-gaap	Postage Expense PostageExpense	592000	USD
CY2020Q1	us-gaap	Postage Expense PostageExpense	616000	USD
CY2021Q1	us-gaap	Supplies Expense SuppliesExpense	392000	USD
CY2020Q1	us-gaap	Supplies Expense SuppliesExpense	394000	USD
CY2021Q1	us-gaap	Professional Fees ProfessionalFees	675000	USD
CY2020Q1	us-gaap	Professional Fees ProfessionalFees	601000	USD
CY2021Q1	us-gaap	Communication Communication	690000	USD
CY2020Q1	us-gaap	Communication Communication	511000	USD
CY2021Q1	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	-79000	USD
CY2020Q1	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	-198000	USD
CY2021Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	3674000	USD
CY2020Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	4102000	USD
CY2021Q1	us-gaap	Noninterest Expense NoninterestExpense	29809000	USD
CY2020Q1	us-gaap	Noninterest Expense NoninterestExpense	29468000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	24801000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	36322000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4987000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7322000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	19814000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	29000000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15656000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16080000	shares
CY2021Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	31000	shares
CY2020Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	21000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15687000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16101000	shares
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.25
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.79
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.25
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.78
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	19814000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	29000000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-20240000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	26714000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	283000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	63000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Reclassification Adjustment For Held To Maturity Transferred To Available For Sale Securities Before Tax OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax	0	USD
CY2020Q1	us-gaap	Other Comprehensive Income Reclassification Adjustment For Held To Maturity Transferred To Available For Sale Securities Before Tax OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax	1562000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-20523000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	28213000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-4918000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	6593000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-15605000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	21620000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4209000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	50620000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	657983000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	29000000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	21620000	USD
CY2020Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.57
CY2020Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	9200000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1009000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2020Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2650	shares
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	122000	USD
CY2020Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	181899	shares
CY2020Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	12971000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	685228000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	701106000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	19814000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-15605000	USD
CY2021Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.58
CY2021Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	9406000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1153000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2021Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	8769	shares
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	385000	USD
CY2021Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	75110	shares
CY2021Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	5762000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	691685000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	19814000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	29000000	USD
CY2021Q1	chco	Amortizationand Accretion Net AmortizationandAccretionNet	1990000	USD
CY2020Q1	chco	Amortizationand Accretion Net AmortizationandAccretionNet	-422000	USD
CY2021Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-440000	USD
CY2020Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	7972000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	1440000	USD
CY2020Q1	us-gaap	Depreciation Depreciation	1325000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	427000	USD
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-824000	USD
CY2021Q1	us-gaap	Pension Expense PensionExpense	158000	USD
CY2020Q1	us-gaap	Pension Expense PensionExpense	181000	USD
CY2021Q1	us-gaap	Pension Contributions PensionContributions	1000000	USD
CY2020Q1	us-gaap	Pension Contributions PensionContributions	0	USD
CY2021Q1	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	232000	USD
CY2020Q1	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	-2339000	USD
CY2021Q1	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	0	USD
CY2020Q1	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	17837000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1153000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1009000	USD
CY2021Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	56000	USD
CY2020Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	121000	USD
CY2021Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	1460000	USD
CY2020Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	1676000	USD
CY2021Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	4682000	USD
CY2020Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	2327000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	4733000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	2229000	USD
CY2021Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	51000	USD
CY2020Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	77000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	438000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	1001000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1318000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5580000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-3273000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	8937000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	19401000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	23127000	USD
CY2021Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	-75822000	USD
CY2020Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	-6442000	USD
CY2021Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	66424000	USD
CY2020Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	94151000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	0	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	26090000	USD
CY2021Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	49368000	USD
CY2020Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	20644000	USD
CY2021Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	24000	USD
CY2020Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	1357000	USD
CY2021Q1	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	452000	USD
CY2020Q1	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	624000	USD
CY2021Q1	chco	Proceeds From The Sale Of Visa Shares ProceedsFromTheSaleOfVISAShares	0	USD
CY2020Q1	chco	Proceeds From The Sale Of Visa Shares ProceedsFromTheSaleOfVISAShares	17837000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1048000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3329000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	119000	USD
CY2021Q1	chco	Proceeds From Sale Of Assets Held For Sale ProceedsFromSaleOfAssetsHeldForSale	0	USD
CY2020Q1	chco	Proceeds From Sale Of Assets Held For Sale ProceedsFromSaleOfAssetsHeldForSale	440000	USD
CY2021Q1	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	1723000	USD
CY2020Q1	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	1412000	USD
CY2021Q1	chco	Payments To Acquire Low Income Housing Tax Credits PaymentsToAcquireLowIncomeHousingTaxCredits	1218000	USD
CY2020Q1	chco	Payments To Acquire Low Income Housing Tax Credits PaymentsToAcquireLowIncomeHousingTaxCredits	346000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	58651000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25575000	USD
CY2021Q1	us-gaap	Net Change Noninterest Bearing Deposits Domestic NetChangeNoninterestBearingDepositsDomestic	67185000	USD
CY2020Q1	us-gaap	Net Change Noninterest Bearing Deposits Domestic NetChangeNoninterestBearingDepositsDomestic	52414000	USD
CY2021Q1	us-gaap	Net Change Interest Bearing Deposits Domestic NetChangeInterestBearingDepositsDomestic	77482000	USD
CY2020Q1	us-gaap	Net Change Interest Bearing Deposits Domestic NetChangeInterestBearingDepositsDomestic	-76100000	USD
CY2021Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	20047000	USD
CY2020Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	22892000	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2020Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	4124000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5762000	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	12971000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	385000	USD
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	122000	USD
CY2021Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	9249000	USD
CY2020Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	9293000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	150088000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-27060000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	228140000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-29508000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	528659000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	140144000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	756799000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	110636000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	3863000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	8118000	USD
CY2021Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2020Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2021Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	1157127000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	32972000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4854000	USD
CY2021Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	1185245000	USD
CY2020Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	1130155000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	49336000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	702000	USD
CY2020Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	1178789000	USD
CY2021Q1	us-gaap	Federal Home Loan Bank Stock And Federal Reserve Bank Stock FederalHomeLoanBankStockAndFederalReserveBankStock	15400000	USD
CY2020Q4	us-gaap	Federal Home Loan Bank Stock And Federal Reserve Bank Stock FederalHomeLoanBankStockAndFederalReserveBankStock	15500000	USD
CY2021Q1	chco	Non Governmental Issues Exceeding10 Shareholders Equity Threshold NonGovernmentalIssuesExceeding10ShareholdersEquityThreshold	0	USD
CY2020Q4	chco	Non Governmental Issues Exceeding10 Shareholders Equity Threshold NonGovernmentalIssuesExceeding10ShareholdersEquityThreshold	0	USD
CY2021Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	323918000	USD
CY2021Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	4454000	USD
CY2021Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	20439000	USD
CY2021Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	400000	USD
CY2021Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	344357000	USD
CY2021Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	4854000	USD
CY2020Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	73478000	USD
CY2020Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	245000	USD
CY2020Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	4135000	USD
CY2020Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	457000	USD
CY2020Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	77613000	USD
CY2020Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	702000	USD
CY2020Q1	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions Additional Credit Losses OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsAdditionalCreditLosses	0	USD
CY2021Q1	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions Additional Credit Losses OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsAdditionalCreditLosses	0	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	16063000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	4470000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	33304000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	34628000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	292485000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	303519000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	813283000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	840636000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1155135000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1183253000	USD
CY2021Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	283000	USD
CY2020Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	134000	USD
CY2021Q1	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0	USD
CY2020Q1	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	71000	USD
CY2021Q1	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	283000	USD
CY2020Q1	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	63000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	0	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	24000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Unrealized Loss EquitySecuritiesFvNiUnrealizedLoss	51000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Unrealized Loss EquitySecuritiesFvNiUnrealizedLoss	2426000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-51000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-2402000	USD
CY2021Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	3546723000	USD
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	3622119000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	24076000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	24549000	USD
CY2021Q1	us-gaap	Notes Receivable Net NotesReceivableNet	3522647000	USD
CY2020Q4	us-gaap	Notes Receivable Net NotesReceivableNet	3597570000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	24549000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	792000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	759000	USD
CY2021Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-440000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	24076000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11589000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	1746000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	818000	USD
CY2020Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	7972000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	24393000	USD
CY2021Q1	chco	Threshold Periodfor Discontinuanceof Interest Accrual ThresholdPeriodforDiscontinuanceofInterestAccrual	P90D
CY2021Q1	us-gaap	Financing Receivable Nonaccrual No Allowance FinancingReceivableNonaccrualNoAllowance	2095000	USD
CY2021Q1	chco	Financing Receivable Nonaccrual With Allowance FinancingReceivableNonaccrualWithAllowance	9989000	USD
CY2021Q1	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	295000	USD
CY2020Q4	us-gaap	Financing Receivable Nonaccrual No Allowance FinancingReceivableNonaccrualNoAllowance	2490000	USD
CY2020Q4	chco	Financing Receivable Nonaccrual With Allowance FinancingReceivableNonaccrualWithAllowance	9742000	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	USD
CY2020Q1	us-gaap	Financing Receivable Nonaccrual Interest Income FinancingReceivableNonaccrualInterestIncome	100000	USD
CY2021Q1	us-gaap	Financing Receivable Nonaccrual Interest Income FinancingReceivableNonaccrualInterestIncome	100000	USD
CY2020Q1	chco	Impaired Financing Receivable Interest Income Interest Forgone ImpairedFinancingReceivableInterestIncomeInterestForgone	100000	USD
CY2021Q1	chco	Impaired Financing Receivable Interest Income Interest Forgone ImpairedFinancingReceivableInterestIncomeInterestForgone	100000	USD
CY2021Q1	us-gaap	Financing Receivable Threshold Period Past Due FinancingReceivableThresholdPeriodPastDue	P30D
CY2021Q1	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	6629000	USD
CY2021Q1	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	3528010000	USD
CY2021Q1	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	12084000	USD
CY2021Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	3546723000	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	8888000	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	3600999000	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	12232000	USD
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	3622119000	USD
CY2021Q1	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	25354000	USD
CY2020Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	26142000	USD
CY2021Q1	chco	Financing Receivable Troubled Debt Restructuring Allowance For Credit Losses FinancingReceivableTroubledDebtRestructuringAllowanceForCreditLosses	1600000	USD
CY2020Q4	chco	Financing Receivable Troubled Debt Restructuring Allowance For Credit Losses FinancingReceivableTroubledDebtRestructuringAllowanceForCreditLosses	1600000	USD
CY2021Q1	us-gaap	Loans And Leases Receivable Impaired Commitment To Lend LoansAndLeasesReceivableImpairedCommitmentToLend	0	USD
CY2021Q1	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	3	contract
CY2021Q1	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	154000	USD
CY2021Q1	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	154000	USD
CY2020Q1	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	11	contract
CY2020Q1	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	877000	USD
CY2020Q1	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	875000	USD
CY2020Q1	chco	Financing Receivables Impaired Troubled Debt Restructuring Provision For Credit Losses FinancingReceivablesImpairedTroubledDebtRestructuringProvisionForCreditLosses	100000	USD
CY2021Q1	chco	Financing Receivables Impaired Troubled Debt Restructuring Provision For Credit Losses FinancingReceivablesImpairedTroubledDebtRestructuringProvisionForCreditLosses	100000	USD
CY2020Q1	us-gaap	Financing Receivables Impaired Troubled Debt Restructuring Write Down FinancingReceivablesImpairedTroubledDebtRestructuringWriteDown	200000	USD
CY2021Q1	us-gaap	Financing Receivables Impaired Troubled Debt Restructuring Write Down FinancingReceivablesImpairedTroubledDebtRestructuringWriteDown	200000	USD
CY2020Q1	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	0	contract
CY2021Q1	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	0	contract
CY2021Q1	us-gaap	Collateral Already Posted Aggregate Fair Value CollateralAlreadyPostedAggregateFairValue	28100000	USD
CY2021Q1	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	83000	USD
CY2020Q1	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	112000	USD
CY2021Q1	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	205000	USD
CY2020Q1	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	203000	USD
CY2021Q1	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-280000	USD
CY2020Q1	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-272000	USD
CY2021Q1	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	158000	USD
CY2020Q1	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	181000	USD
CY2021Q1	chco	Combined Federal And State Income Tax Rate CombinedFederalAndStateIncomeTaxRate	0.24
CY2021Q1	chco	Combined Federal And State Income Tax Rate CombinedFederalAndStateIncomeTaxRate	0.24
CY2020Q1	chco	Combined Federal And State Income Tax Rate CombinedFederalAndStateIncomeTaxRate	0.24
CY2020Q1	chco	Combined Federal And State Income Tax Rate CombinedFederalAndStateIncomeTaxRate	0.24
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	19814000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	29000000	USD
CY2021Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	-179000	USD
CY2020Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	-263000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	19635000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	28737000	USD
CY2021Q1	us-gaap	Distributed Earnings DistributedEarnings	9037000	USD
CY2020Q1	us-gaap	Distributed Earnings DistributedEarnings	9117000	USD
CY2021Q1	us-gaap	Undistributed Earnings Diluted UndistributedEarningsDiluted	10598000	USD
CY2020Q1	us-gaap	Undistributed Earnings Diluted UndistributedEarningsDiluted	19620000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	19635000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	28737000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15656000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16080000	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	31000	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	21000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15687000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16101000	shares
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.25
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.79
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.25
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.78
CY2021Q1	us-gaap	Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal	0	USD
CY2021Q1	us-gaap	Derivative Credit Risk Valuation Adjustment Derivative Assets DerivativeCreditRiskValuationAdjustmentDerivativeAssets	0	USD

Files In Submission

Name	View Source	Status
0000726854-21-000093-index-headers.html	Edgar Link	pending
0000726854-21-000093-index.html	Edgar Link	pending
0000726854-21-000093.txt	Edgar Link	pending
0000726854-21-000093-xbrl.zip	Edgar Link	pending
chco-20210331.htm	Edgar Link	pending
chco-20210331.xsd	Edgar Link	pending
chco-20210331_cal.xml	Edgar Link	unprocessable
chco-20210331_def.xml	Edgar Link	unprocessable
chco-20210331_g1.jpg	Edgar Link	pending
chco-20210331_htm.xml	Edgar Link	completed
chco-20210331_lab.xml	Edgar Link	unprocessable
chco-20210331_pre.xml	Edgar Link	unprocessable
exhibit31a03-31x2021.htm	Edgar Link	pending
exhibit31b03-31x2021.htm	Edgar Link	pending
exhibit32a03-31x2021.htm	Edgar Link	pending
exhibit32b03-31x2021.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CHCO
City Holding Co Stock $chco

2021 Q1 Form 10-Q Financial Statement

#000072685421000093 Filed on May 06, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHCO City Holding Co Stock $chco

2021 Q1 Form 10-Q Financial Statement

#000072685421000093 Filed on May 06, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHCO
City Holding Co Stock $chco